HK142395A - Phenylquinolinecarboxylic acids and derivatives as antitumor agents - Google Patents

Phenylquinolinecarboxylic acids and derivatives as antitumor agents

Info

Publication number
HK142395A
HK142395A HK142395A HK142395A HK142395A HK 142395 A HK142395 A HK 142395A HK 142395 A HK142395 A HK 142395A HK 142395 A HK142395 A HK 142395A HK 142395 A HK142395 A HK 142395A
Authority
HK
Hong Kong
Prior art keywords
carbon atoms
compound
solvent
alkyl
pharmaceutical carrier
Prior art date
Application number
HK142395A
Other languages
German (de)
English (en)
French (fr)
Inventor
Paul Hesson David
Original Assignee
The Du Pont Merck Pharmaceutical Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Du Pont Merck Pharmaceutical Company filed Critical The Du Pont Merck Pharmaceutical Company
Publication of HK142395A publication Critical patent/HK142395A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK142395A 1983-07-22 1995-09-07 Phenylquinolinecarboxylic acids and derivatives as antitumor agents HK142395A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51631983A 1983-07-22 1983-07-22
US60510484A 1984-04-30 1984-04-30

Publications (1)

Publication Number Publication Date
HK142395A true HK142395A (en) 1995-09-15

Family

ID=27058797

Family Applications (1)

Application Number Title Priority Date Filing Date
HK142395A HK142395A (en) 1983-07-22 1995-09-07 Phenylquinolinecarboxylic acids and derivatives as antitumor agents

Country Status (16)

Country Link
EP (1) EP0133244B1 (enExample)
AU (1) AU583793B2 (enExample)
CA (1) CA1288436C (enExample)
DE (1) DE3483704D1 (enExample)
DK (1) DK358784A (enExample)
ES (1) ES534509A0 (enExample)
FI (1) FI86987C (enExample)
GR (1) GR82234B (enExample)
HK (1) HK142395A (enExample)
HU (1) HU194832B (enExample)
IE (1) IE57627B1 (enExample)
IL (1) IL72471A (enExample)
NO (1) NO167510C (enExample)
NZ (1) NZ208966A (enExample)
PT (1) PT78960B (enExample)
SU (2) SU1393314A3 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889862A (en) * 1986-08-28 1989-12-26 E. I. Du Pont De Nemours And Company Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids
WO1989006227A1 (en) * 1987-12-28 1989-07-13 The Dow Chemical Company Phenoxyphenoxypropionates, intermediates thereof and methods of preparation
US4861783A (en) * 1988-04-26 1989-08-29 E. I. Du Pont De Nemours And Company 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
US4968702A (en) * 1989-01-17 1990-11-06 American Cyanamid Company Substituted quinolinecarboxylic acids
US4918077A (en) * 1989-01-25 1990-04-17 E. I. Du Pont De Nemours & Co., Inc. 3-phenyl-5,6-dihydrobenz(c)acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents
DE3905339A1 (de) * 1989-02-22 1990-09-06 Basf Ag Chinolin-4-carbonsaeurederivate und deren verwendung
US5393891A (en) * 1993-06-08 1995-02-28 The Du Pont Merck Pharmaceutical Company Immunoassay reagents and methods for detecting brequinar and analogs
TW416948B (en) * 1993-12-28 2001-01-01 Merck & Co Inc Process for the preparation of leukotriene antagonists
AU747026B2 (en) * 1997-05-28 2002-05-09 Aventis Pharmaceuticals Inc. Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
WO1999032482A1 (en) * 1997-12-19 1999-07-01 Eli Lilly And Company Hypoglycemic imidazoline compounds
JPWO2004002484A1 (ja) * 2002-06-26 2005-10-27 協和醗酵工業株式会社 ホスホジエステラーゼ阻害剤
TW200804288A (en) * 2005-12-12 2008-01-16 Astrazeneca Ab Alkylsulphonamide quinolines
US8232310B2 (en) * 2006-12-29 2012-07-31 Georgetown University Targeting of EWS-FLI1 as anti-tumor therapy
CA2869513C (en) 2012-04-12 2020-07-07 Georgetown University Methods and compositions for treating ewings sarcoma family of tumors
AU2014340398A1 (en) 2013-10-24 2016-06-09 Georgetown University Methods and compositions for treating cancer
AU2014352920A1 (en) 2013-11-22 2016-06-23 Genzyme Corporation Novel methods for treating neurodegenerative diseases
MX388564B (es) 2014-10-09 2025-03-20 Oncternal Therapeutics Inc Compuestos de indolinona y usos de los mismos.
KR102514814B1 (ko) 2016-03-31 2023-03-27 온크터널 테라퓨틱스, 인코포레이티드. 인돌린 유사체 및 이의 용도
KR102282794B1 (ko) 2016-07-29 2021-07-27 온크터널 테라퓨틱스, 인코포레이티드. 인돌리논 화합물의 용도
CA3165512A1 (en) * 2019-12-26 2021-07-01 Ohio State Innovation Foundation Methods and compositions for inhibition of dihydroorotate dehydrogenase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE502610A (enExample) * 1950-04-18
US2888346A (en) * 1955-08-22 1959-05-26 Gen Aniline & Film Corp Ultra-violet absorbing compounds

Also Published As

Publication number Publication date
PT78960A (en) 1984-08-01
EP0133244A3 (en) 1985-12-11
NO842969L (no) 1985-01-23
IL72471A0 (en) 1984-11-30
NO167510B (no) 1991-08-05
HU194832B (en) 1988-03-28
IE841873L (en) 1985-01-22
IL72471A (en) 1988-11-15
NZ208966A (en) 1986-12-05
EP0133244B1 (en) 1990-12-05
ES8507498A1 (es) 1985-09-01
SU1452480A3 (ru) 1989-01-15
CA1288436C (en) 1991-09-03
AU583793B2 (en) 1989-05-11
PT78960B (en) 1986-10-20
GR82234B (enExample) 1984-12-13
DE3483704D1 (de) 1991-01-17
ES534509A0 (es) 1985-09-01
FI842928A0 (fi) 1984-07-20
FI842928L (fi) 1985-01-23
DK358784D0 (da) 1984-07-20
AU3085284A (en) 1985-01-24
SU1393314A3 (ru) 1988-04-30
NO167510C (no) 1991-11-13
IE57627B1 (en) 1993-02-10
EP0133244A2 (en) 1985-02-20
FI86987B (fi) 1992-07-31
DK358784A (da) 1985-01-23
FI86987C (fi) 1992-11-10
HUT35248A (en) 1985-06-28

Similar Documents

Publication Publication Date Title
US4680299A (en) 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
EP0133244B1 (en) Phenylquinolinecarboxylic acids and derivatives as antitumor agents
CA1087205A (en) 2-amino-3-(5-and 6-)benzoylphenylacetic acids, esters and metal salts thereof
US4374990A (en) Cyclic diamine derivatives
JPH0684336B2 (ja) 殺生物性芳香族化合物、その合成および医薬としてのその使用
US4639454A (en) Phenylquinazolinecarboxylic acids and derivatives as cancer chemotherapeutic agents
US4053607A (en) Aryloxypyridine for treating hyperglycaemia
JPH0741461A (ja) スルホン酸エステル誘導体
EP2208725A1 (en) Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications
Aytemir et al. Anticonvulsant and neurotoxicity evaluation of some novel kojic acids and allomaltol derivatives
EP1142885B1 (en) 2-(n-cyanoimino)thiazolidin-4-one derivatives
EP0145010B1 (en) Carbostyril derivatives
EP0228959B1 (en) Aminostyryl compound, leukotriene antagonistic composition containing the same as effective ingredients and method of antagonizing srs by employing the same
JP4001636B2 (ja) ガンおよびaidsの処置のための活性化ヨード誘導体
AU623481B2 (en) 3-phenyl-5,6-dihydrobenz(c)acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents
US5032597A (en) Method of using phenylquinolinecarboxylic acids and derivatives for lymthoid leukemia treatment in a mammal
US20190330142A1 (en) Inhibitors of mtor-deptor interactions and methods of use thereof
US4297357A (en) N-Phenethylacetamide compounds and process for preparation thereof
JPH0519549B2 (enExample)
JPH01250316A (ja) 抗脂血剤
EP0282077A2 (en) Pyridyloxy derivatives
GB2062637A (en) Imidazolylethoxy derivatives of quinoline-2-or 4-methanols
RU2126001C1 (ru) Производные пиперазина и фармацевтическая композиция на их основе
US7863323B1 (en) Flavonols
CS221810B2 (en) Method of making the new isochinoline derivatives with contanets of sulphur

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)